M&A Deal Summary

Eximia Acquires Integrated Clinical Trial Services

On October 16, 2024, Eximia acquired life science company Integrated Clinical Trial Services

Acquisition Highlights
  • This is Eximia’s 2nd transaction in the Life Science sector.
  • This is Eximia’s 2nd transaction in the United States.
  • This is Eximia’s 1st transaction in Iowa.

M&A Deal Summary
Date 2024-10-16
Target Integrated Clinical Trial Services
Sector Life Science
Buyer(s) Eximia
Deal Type Add-on Acquisition

Target

Integrated Clinical Trial Services

West Des Moines, Iowa, United States
Integrated Clinical Trial Services specializes in conducting clinical trials for pharmaceutical companies. Integrated Clinical Trial Services focuses on patient recruitment, retention, and compliance throughout the clinical trial process. Integrated Clinical Trial Services was founded in 2005 and is based in West Des Moines, Iowa.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eximia

Dover, Delaware, United States
Category Company
Sector Life Science
DESCRIPTION

Eximia is a multi-site, multi-therapeutic, clinical research site network serving pharmaceutical, biotech companies, and CROs and providing research services across a diverse range of therapeutic indications with access to underrepresented patient populations. Eximia is based in Dover, Delaware.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Iowa) 1 of 1
Country (United States) 2 of 2
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-02 Tidewater Clinical Research

Norfolk, Virginia, United States

Tidewater Clinical Research specializes in conducting clinical trials focused on women's health. Tidewater Clinical Research was founded in 1994 and is based in Norfolk, Virginia.

Buy -
Mergr

Product

Company

Legal